Effects of remimazolam tosilate on gastrointestinal hormones and gastrointestinal motility in patients undergoing gastrointestinal endoscopy with sedation: a randomized control trial.
Tianyi YangYinji ZhouMingshan WangLina ZhangBing LiuLixin SunFei ShiYang YuanGaofeng ZhangPublished in: Postgraduate medical journal (2024)
Compared with propofol used during gastrointestinal endoscopy with sedation, remimazolam tosilate mildly inhibits the serum motilin and gastrin levels, potentially facilitating the recovery of gastrointestinal motility.